Tahsin Emirhan Tekoglu

5PUBLICATIONS
29CO-AUTHORS
Molecular targetsPredictive and prognostic markersPharmaceutical delivery technologiesStructural properties of condensed matterBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 29, 2026
Evaluation of Tissue from Patients with Prostate Cancer Identifies B7-H3 as an Androgen-Regulated, Broadly Expressed, Combinatorial Therapeutic Target.

|Dec 04, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer.

Betul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas

|Oct 22, 2025
Baited SELEX: Drug-Directed Selection of Aptamers to PSMA for In Vivo Targeting of Prostate Cancer Xenografts in Mice.

Kun Liu, Nicole Robinson, Emirhan Tekoglu

|Jan 27, 2025
AR-V7 condensates drive androgen-independent transcription in castration resistant prostate cancer.

Shabnam Massah, Nicholas Pinette, Jane Foo

|Dec 21, 2022
Exploring a diverse world of effector domains and amyloid signaling motifs in fungal NLR proteins.

Jakub W Wojciechowski, Emirhan Tekoglu, Marlena Gąsior-Głogowska

Pageof 1